Ascend Laboratories, LLC recalls Amlodipine and Olmesartan Medoxomil Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- What's wrong
- Out of specification due to dissolution.
- Products
-
- Amlodipine and Olmesartan Medoxomil Tablets
- Company
- Ascend Laboratories, LLC
- Where it was sold
-
Nationwide within the United States
- Units affected
- 11,424 bottles.
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.